Reuters logo
BRIEF-Factor Therapeutics starts phase II trial of a novel topical biologic
December 20, 2016 / 2:10 PM / a year ago

BRIEF-Factor Therapeutics starts phase II trial of a novel topical biologic

Dec 20 (Reuters) - Factor Therapeutics Ltd:

* Factor Therapeutics announces commencement of phase II trial of a novel topical biologic for the treatment of chronic wounds

* Factor Therapeutics- company plans to provide an enrolment update in Q1 2017, and is targeting a top-line read-out of efficacy by Q4 2017 for vf001 Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below